EUVIMEDEUVIMED entdecken
Crossref

Risk factors for future bleeding in patients with mild bleeding disorders: longitudinal data from the Vienna Bleeding Biobank

Dino Mehic, Georg Neubauer, Florian Janig, Alexandra Kaider, Cihan Ay, Ingrid Pabinger, Johanna Gebhart

Journal of Thrombosis and Haemostasis · 2023-07 · 21 (7) · 1757-1768

DOI: 10.1016/j.jtha.2023.03.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Thrombosis and Haemostasis, 2023-07. Verfasst von Dino Mehic und 6 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria; Institute of Vascular Bi…. Hauptthemen laut MEDLINE: Hemorrhagic Disorders, Blood Coagulation Disorders, Hemostatics. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: City of Vienna, CSL Behring, Oesterreichische Nationalbank.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The future bleeding risk, especially after hemostatic challenges, and thus the requirement for hemostatic treatment in patients with mild-to-moderate bleeding disorders (MBDs) is largely unknown. OBJECTIVES: This study aimed to prospectively examine the recurrence of bleeding symptoms and clinical risk factors for future bleeding in patients with MBD, including patients with bleeding disorder of unknown cause (BDUC). METHODS: Bleeding symptoms of patients with MBD included in the Vienna Bleeding Biobank were re-evaluated at in-person follow-up visits or by mail. RESULTS: In total, 392 patients, including 62.8% with BDUC, were investigated for the recurrence of bleeding events. During the follow-up time of median (IQR) 4.3 years (2.6-6.7), 72% of patients had at least 1 bleeding event. Most persistent bleeding manifestations were hematomas (n = 146/245, 59.6%) and bleeding from small wounds (n = 69/141, 48.9%), followed by epistaxis (n = 42/132, 31.8%), oral mucosal bleeding (n = 26/87, 29.9%), and joint bleeding (n = 7/14, 50.0%). Patients with previous postinterventional bleeding had a significantly increased risk for bleeding events after surgery (n = 33/114, 29.0 %) or tooth extraction (n = 16/39, 41.0%). A high bleeding score (OR [95% CI], 1.14 [1.05 to 2.94], per 1 unit) and follow-up time (OR [95% CI], 1.23 [1.12 to 1.36], per 1 year) were independently associated with any bleeding event. For bleeding after hemostatic challenges, blood group O (OR, 3.17 [1.57 to 6.40]), previous postsurgical bleeding (OR, 2.40 [1.06 to 5.46]), and an established diagnosis (OR, 2.07 [1.04 to 4.10]) were independent risk factors. CONCLUSION: Patients with MBD have a high risk for recurrent bleeding. This encourages prophylactic hemostatic treatment in patients with MBD, particularly when they face hemostatic challenges.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hemorrhagic DisordersBlood Coagulation DisordersHemostaticsHumansBiological Specimen BanksHemorrhageRisk Factors

Stichwörter der Autor:innen

blood coagulation disordersblood losshemorrhageinheritedsurgicalthrombastheniavon Willebrand disease

Substanzen

Hemostatics

Autor:innen und Institutionen

  • Clinical Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria; Institute of Vascular Biology and Thrombosis Research, Centre of Physiology and Pharmacology,…
  • Clinical Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
  • Center for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna, Vienna, Austria.
  • Clinical Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria. Electronic address: https://twitter.com/Cihan_Ay_MD.
  • Clinical Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria. Electronic address: johanna.gebhart@meduniwien.ac.at.

Förderung

  • City of Vienna
  • CSL Behring
  • Oesterreichische Nationalbank

Zitieren

APA

Mehic, D., Neubauer, G., Janig, F., Kaider, A., Ay, C., Pabinger, I., & Gebhart, J. (2023). Risk factors for future bleeding in patients with mild bleeding disorders: longitudinal data from the Vienna Bleeding Biobank. Journal of Thrombosis and Haemostasis, 21(7), 1757-1768. https://doi.org/10.1016/j.jtha.2023.03.006

Vancouver

Mehic D, Neubauer G, Janig F, Kaider A, Ay C, Pabinger I, et al. Risk factors for future bleeding in patients with mild bleeding disorders: longitudinal data from the Vienna Bleeding Biobank. Journal of Thrombosis and Haemostasis. 2023;21(7):1757-1768. doi:10.1016/j.jtha.2023.03.006

BibTeX
@article{Mehic2023,
  author = {Mehic, Dino and Neubauer, Georg and Janig, Florian and Kaider, Alexandra and Ay, Cihan and Pabinger, Ingrid and Gebhart, Johanna},
  title = {Risk factors for future bleeding in patients with mild bleeding disorders: longitudinal data from the Vienna Bleeding Biobank},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2023},
  volume = {21},
  number = {7},
  pages = {1757--1768},
  doi = {10.1016/j.jtha.2023.03.006}
}
Kostenlos starten →